Researchers from GEIMAC group have developed a clinical screening test to assess cognitive deficits in psychiatry
The SCIP-S test is a screening tool to assess the most common cognitive deficits of patients suffering psychotic or affective disorders. Researchers from GEIMAC group of the Institute of Neurosciences arranged an agreement with a relevant biopharmaceutical company, which provided funds for the validation process...